Evidence map›Paper›PMID 24192548›Full record

ArticleJournal of vascular research2013

Vasopressin-induced constriction of the isolated rat occipital artery is segment dependent.

Stephen P Chelko, Chad W Schmiedt, Tristan H Lewis, Stephen J Lewis, Tom P Robertson

Open access · bronzeAbstract readComparative Study
In one paragraph

Article in Journal of vascular research, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.2field-weighted citation impact, top 39% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 5 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Stephen P ChelkoDepartment of Cardiology, Johns Hopkins University School of Medicine, Baltimore, Md., USA.
Chad W Schmiedt
Tristan H Lewis
Stephen J Lewis
Tom P Robertson
Case Western Reserve University · US

Funding

Vagal afferent cell bodies as sensors of blood-borne factorsR01NS054117 · NINDS · UNIVERSITY OF VIRGINIA · PI LEWIS, STEPHEN JOHN · 2007 to 2010
$1.2M
NINDS NIH HHS 1R01NS054117-01A2NINDS NIH HHS R01 NS054117
6 · The paper itself

Abstract

backgroundCirculating factors delivered to the nodose ganglion (NG) by the occipital artery (OA) have been shown to affect vagal afferent activity, and thus the contractile state of the OA may influence blood flow to the NG.

methodsOA were isolated and bisected into proximal and distal segments relative to the external carotid artery.

resultsBisection highlighted stark differences between maximal contractile responses and OA sensitivity. Specifically, maximum responses to vasopressin and the V1 receptor agonist were significantly higher in distal than proximal segments. Distal segments were significantly more sensitive to 5-hydroxytryptamine (5-HT) and the 5-HT2 receptor agonist than proximal segments. Angiotensin II (AT)2, V2 and 5-HT(1B/1D) receptor agonists did not elicit vascular responses. Additionally, AT1 receptor agonists elicited mild, yet not significantly different maximal responses between segments.

conclusionThe results of this study are consistent with contractile properties of rat OA being mediated via AT1, V1 and 5-HT2 receptors and dependent upon the OA segment. Furthermore, vasopressin-induced constriction of the OA, regardless of a bolus dose or a first and second concentration-response curve, retained this unique segmental difference. We hypothesize that these segmental differences may be important in the regulation of blood flow through the OA in health and disease.

Indexed as

Angiotensin II Type 1 Receptor BlockersAnimalsArginine VasopressinCerebral ArteriesDose-Response Relationship, DrugHormone AntagonistsMaleNodose GanglionOccipital LobeRatsRats, Sprague-DawleyReceptor, Angiotensin, Type 1Receptors, Serotonin, 5-HT2Receptors, VasopressinSerotonin AntagonistsSerotonin Receptor AgonistsAngiotensin II Type 1 Receptor BlockersArginine VasopressinHormone AntagonistsReceptor, Angiotensin, Type 1Receptors, Serotonin, 5-HT2Receptors, VasopressinSerotonin AntagonistsSerotonin Receptor AgonistsVasoconstrictor Agents

Identifiers

PMID24192548
PMCPMC3942879
OpenAlexW2019148704

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.